39.91
price up icon0.20%   0.08
after-market アフターアワーズ: 39.91
loading
前日終値:
$39.83
開ける:
$39.91
24時間の取引高:
3.76M
Relative Volume:
0.80
時価総額:
$81.28B
収益:
$40.95B
当期純損益:
$5.16B
株価収益率:
18.38
EPS:
2.1708
ネットキャッシュフロー:
$5.47B
1週間 パフォーマンス:
-0.40%
1か月 パフォーマンス:
+5.11%
6か月 パフォーマンス:
+7.00%
1年 パフォーマンス:
-9.60%
1日の値動き範囲:
Value
$39.76
$40.13
1週間の範囲:
Value
$39.57
$40.57
52週間の値動き範囲:
Value
$31.71
$44.26

Gsk Plc Adr Stock (GSK) Company Profile

Name
名前
Gsk Plc Adr
Name
セクター
Healthcare (1146)
Name
電話
-
Name
住所
-
Name
職員
68,629
Name
Twitter
@GSK
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
GSK's Discussions on Twitter

GSK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
GSK
Gsk Plc Adr
39.91 80.25B 40.95B 5.16B 5.47B 2.1708
Drug Manufacturers - General icon
LLY
Lilly Eli Co
734.17 659.82B 53.26B 13.80B -50.20M 15.30
Drug Manufacturers - General icon
JNJ
Johnson Johnson
176.79 425.05B 90.62B 22.66B 18.18B 9.35
Drug Manufacturers - General icon
ABBV
Abbvie Inc
208.06 368.08B 58.33B 3.73B 18.24B 2.10
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
126.89 245.16B 53.40B 13.68B 16.89B 6.9231
Drug Manufacturers - General icon
MRK
Merck Co Inc
84.07 212.29B 63.43B 16.42B 14.72B 6.49

Gsk Plc Adr Stock (GSK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-06-03 ダウングレード Berenberg Buy → Hold
2025-04-15 開始されました Exane BNP Paribas Neutral
2025-02-12 開始されました Morgan Stanley Equal-Weight
2024-11-15 ダウングレード Deutsche Bank Buy → Hold
2024-11-12 ダウングレード Jefferies Buy → Hold
2024-10-31 ダウングレード Guggenheim Buy → Neutral
2024-07-08 ダウングレード UBS Buy → Neutral
2024-05-30 開始されました Goldman Neutral
2024-03-04 アップグレード Guggenheim Neutral → Buy
2024-02-13 アップグレード Citigroup Neutral → Buy
2024-01-23 開始されました Morgan Stanley Equal-Weight
2024-01-16 再開されました UBS Buy
2024-01-03 アップグレード Jefferies Hold → Buy
2023-07-14 開始されました HSBC Securities Reduce
2023-03-17 アップグレード Deutsche Bank Hold → Buy
2023-02-27 再開されました Goldman Buy
2023-01-03 ダウングレード JP Morgan Neutral → Underweight
2022-12-05 ダウングレード BofA Securities Neutral → Underperform
2022-11-11 ダウングレード UBS Neutral → Sell
2022-09-15 アップグレード Credit Suisse Underperform → Neutral
2022-09-08 ダウングレード Jefferies Buy → Hold
2022-08-05 再開されました Morgan Stanley Equal-Weight
2022-07-21 再開されました Citigroup Neutral
2022-02-11 ダウングレード DZ Bank Buy → Hold
2021-11-05 アップグレード Barclays Underweight → Equal Weight
2021-06-24 アップグレード Deutsche Bank Sell → Hold
2021-03-23 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-04 ダウングレード Deutsche Bank Hold → Sell
2021-01-20 ダウングレード Credit Suisse Neutral → Underperform
2021-01-15 開始されました Deutsche Bank Hold
2020-11-02 アップグレード Liberum Hold → Buy
2020-09-29 開始されました Berenberg Buy
2020-02-12 ダウングレード Shore Capital Hold → Sell
2020-01-16 ダウングレード Barclays Equal Weight → Underweight
2019-12-02 開始されました SVB Leerink Outperform
2019-11-21 アップグレード UBS Neutral → Buy
2019-10-11 アップグレード Cantor Fitzgerald Hold → Buy
2019-09-03 再開されました Citigroup Neutral
2019-09-03 アップグレード Societe Generale Sell → Buy
2019-08-13 再開されました JP Morgan Neutral
2019-06-17 再開されました Morgan Stanley Underweight
2019-03-08 ダウングレード Shore Capital Buy → Hold
2019-02-22 ダウングレード UBS Buy → Neutral
2019-01-14 ダウングレード Exane BNP Paribas Outperform → Neutral
2018-12-11 再開されました Jefferies Buy
2018-10-09 開始されました Guggenheim Neutral
2018-08-30 ダウングレード Liberum Buy → Hold
2018-04-04 アップグレード Exane BNP Paribas Neutral → Outperform
2018-03-22 アップグレード Morgan Stanley Underweight → Equal-Weight
2018-02-09 アップグレード Kepler Reduce → Hold
すべてを表示

Gsk Plc Adr (GSK) 最新ニュース

pulisher
Aug 27, 2025

GSK Plc ADR Inc. (GSK) Price Performance: The Impact of Insider Trading and Institutional Holdings - investchronicle.com

Aug 27, 2025
pulisher
Aug 20, 2025

Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing - GlobeNewswire Inc.

Aug 20, 2025
pulisher
Aug 14, 2025

GSK Plc ADR (GSK Stock: A Sea of Opportunity - investchronicle.com

Aug 14, 2025
pulisher
Aug 13, 2025

Pomerantz LLP Investigates GSK Securities Fraud Claims - AInvest

Aug 13, 2025
pulisher
Aug 04, 2025

The Best Healthcare Stocks to Buy - Morningstar

Aug 04, 2025
pulisher
Aug 03, 2025

What’s Next for Pharma Stocks After Trump’s Drug Price Ultimatum? - Morningstar

Aug 03, 2025
pulisher
Jul 31, 2025

Company News for Jul 31, 2025 - The Globe and Mail

Jul 31, 2025
pulisher
Jul 30, 2025

GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise - TradingView

Jul 30, 2025
pulisher
Jul 27, 2025

Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology - Ariva

Jul 27, 2025
pulisher
Jul 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 21, 2025
pulisher
Jul 15, 2025

GSK Plc ADR (GSK) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Fifth Third Bancorp Inc. (FITB) Price Performance Over the Years: A Comparative Study - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Navigating YMM Stock: Full Truck Alliance Co Ltd ADR Journey - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

GDS Holdings Limited ADR (GDS) Stock: Navigating a Year of Volatility - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

The Future of Microvast Holdings Inc: Analyzing MVST - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

SES AI Corporation (SES) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

SKYQ’s Stock Woes: Down -53.24% in 6 Months, Down -53.24% in Just 5 Days - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Antero Resources Corp (AR) Stock: A Year of Declines and Increases - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

The Psychology of HUYA Inc ADR Inc. (HUYA) Price Performance: Understanding Market Sentiment - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

American Resources Corporation: Analyzing AREC Stock Trends - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

MSP Recovery Inc (MSPR) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Coty Inc (COTY) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Behind Palladyne AI Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

NVO’s 2025 Market Dance: Down -51.70% – Time to Invest? - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Bilibili Inc ADR (BILI) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Captivision Inc Inc. (CAPT) Price Performance: The Role of Supply and Demand - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

Charting the Course: Castellum Inc’s CTM Stock Prospects - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

IBG’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

LQR House Inc (YHC) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

INKT’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 15, 2025
pulisher
Jul 14, 2025

Crossmark Global Holdings Inc. Reduces Stock Holdings in ARM Holdings PLC Sponsored ADR (NASDAQ:ARM) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults - The Globe and Mail

Jul 14, 2025
pulisher
Jul 14, 2025

FDA Accepts GSK Filing For Expanded Use Of RSV Shot In Younger Adults - Barchart.com

Jul 14, 2025
pulisher
Jul 14, 2025

Argentina Lithium & Energy (CVE:LIT) Shares Down 12.5% – What’s Next? - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Brown Advisory Inc. Increases Holdings in Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Callan Capital LLC Raises Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Brown Advisory Inc. Boosts Position in Schwab US Large-Cap ETF (NYSEARCA:SCHX) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

KBR, Inc. (NYSE:KBR) Holdings Trimmed by M&T Bank Corp - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Invesco RAFI Developed Markets ex-U.S. ETF (NYSEARCA:PXF) Position Increased by Bank of New York Mellon Corp - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Verisk Analytics, Inc. (NASDAQ:VRSK) Shares Sold by Stratos Wealth Partners LTD. - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Post Resch Tallon Group Inc. Has $818,000 Stock Position in NVIDIA Corporation (NASDAQ:NVDA) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Alphabet Inc. (NASDAQ:GOOGL) Shares Purchased by Interchange Capital Partners LLC - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Crossmark Global Holdings Inc. Purchases New Stake in Cushman & Wakefield PLC (NYSE:CWK) - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

4,270 Shares in iShares California Muni Bond ETF (NYSEARCA:CMF) Bought by Crossmark Global Holdings Inc. - Defense World

Jul 14, 2025
pulisher
Jul 14, 2025

Wall Street Zen Upgrades LCI Industries (NYSE:LCII) to Buy - Defense World

Jul 14, 2025
pulisher
Jul 12, 2025

Citigroup Forecasts Strong Price Appreciation for Establishment Labs (NASDAQ:ESTA) Stock - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Is Your Investment Portfolio Ready for a US-EU Trade Deal? - Morningstar

Jul 11, 2025
pulisher
Jul 11, 2025

Amalgamated Bank Sells 311 Shares of Benchmark Electronics, Inc. (NYSE:BHE) - Defense World

Jul 11, 2025

Gsk Plc Adr (GSK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general SNY
$50.11
price down icon 0.38%
$113.92
price down icon 0.72%
drug_manufacturers_general PFE
$25.07
price up icon 0.60%
$287.97
price down icon 0.56%
drug_manufacturers_general NVO
$56.44
price up icon 1.99%
drug_manufacturers_general MRK
$84.07
price down icon 1.08%
大文字化:     |  ボリューム (24 時間):